This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Jinshan Shen: Innovator in Antibody Treatment
Introduction
Jinshan Shen is a notable inventor based in Skillman, NJ (US). He has made significant contributions to the field of medical treatments, particularly in the area of antibody therapies. His innovative work has led to the development of a unique method for treating diseases related to Interferon gamma inducible protein 10 (IP-10).
Latest Patents
Jinshan Shen holds 1 patent for his invention titled "IP-10 antibody dosage escalation regimens." This patent outlines a method for treating IP-10-related diseases by administering a predetermined dosage of an anti-IP-10 antibody. The process involves monitoring the antibody levels in the subject and adjusting the dosage accordingly to ensure effective treatment.
Career Highlights
Jinshan Shen is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to improve therapeutic options for patients suffering from IP-10-related conditions.
Collaborations
Throughout his career, Jinshan has collaborated with esteemed colleagues, including Allison Y Luo and Wendy L Trigona. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Jinshan Shen's contributions to antibody treatment methodologies exemplify the impact of innovative thinking in the medical field. His patent on IP-10 antibody dosage escalation regimens represents a significant advancement in therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile